Head-to-head · Value Score
bmiMD vs PlexusDx
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, PlexusDx a 80. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-namePlexusDx
#65 · Grade B · Good Value
Est. first month
From $129/mo (compounded)
Save ~90% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 80 — an est. $99/mo first month, with no teaser step-up baked in. PlexusDx isn't out of it: Shoppers wanting nationwide compounded GLP-1 with optional genetic-test personalization.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | PlexusDx |
|---|---|---|
| Value Score | 89 (A) | 80 (B) |
| Est. first month | $99/mo | From $129/mo (compounded) |
| Save vs brand-name | ~93% | ~90% |
| Semaglutide | $99/mo | From $129/mo (compounded) |
| Tirzepatide | $139/mo | From $249/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
PlexusDx
PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states.
Why it's a deal
- Licensed providers available in all 50 states
- Range of options including low-cost microdose GLP-1 from $129/mo
- Optional Precision Peptide genetic panel adds a personalization angle
- Independent clinician review via state-licensed telehealth platform
- Compounded medications from state-licensed pharmacies
The fine print
- Compounded medications only; no FDA-approved brand options
- Specific compounding pharmacies not named
- Genetic-panel upsell may not add clinical value for everyone
- Tirzepatide pricing from $249/mo is higher than budget rivals
- No insurance accepted
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to PlexusDx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.